Short Trade Idea
Enter your short position between $196.70 (yesterday’s intra-day low) and $200.07 (an intermediate horizontal resistance level).
Top Regulated Brokers
Market Index Analysis
Quest Diagnostics (NYSE:DGX) is a member of the S&P 500 Index.
This index trades near all-time highs with rising bearish catalysts and worsening macroeconomic headwinds.
The Bull Bear Power Indicator for the S&P 500 Index is bearish with a descending trendline.
Market Sentiment Analysis
Equity futures are moving higher, building on yesterday’s advance following Friday’s one-day plunge. AI is leading the way again, boosted after Marvell Technology’s (NASDAQ:MRVL) inclusion into the S&P 500 and OpenAI’s announcement that it has taken the first step towards its IPO. Inflationary pressures continue amid the war in Iran, while the SpaceX IPO is oversubscribed, with $150 billion in orders for $75 billion in shares, and worries over a potential market top have increased because of the blockbuster listing.
Quest Diagnostics Fundamental Analysis
Quest Diagnostics is a clinical laboratory that offers diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing.
So, why am I bearish on DGX despite its recent uptrend?
The potential for higher interest rates for longer is cutting into free cash flow as day-to-day expenses are surging at Quest Diagnostics, resulting in a sharp drop in operating margins. DGX refinanced $500 million in debt with a coupon rate of 3.45% for a new batch of senior notes due in 2036 with a coupon rate of 5.00%. Quest Diagnostics also reports declining earnings per share despite revenue growth, another red flag.
Metric | Value | Verdict |
P/E Ratio | 21.79 | Bullish |
P/B Ratio | 3.01 | Bearish |
PEG Ratio | 1.54 | Bullish |
Current Ratio | 1.18 | Bearish |
ROIC-WACC Ratio | Positive | Bullish |
The price-to-earnings (P/E) ratio of 21.79 makes DGX an inexpensive stock. By comparison, the P/E ratio for the S&P 500 Index is 31.90.
The average analyst price target for DGX is $223.44. This suggests moderate upside potential, but downside risks remain greater.
Quest Diagnostics Technical Analysis
Today’s DGX Signal
The DGX D1 chart shows price action inside a bearish price channel.
It also shows price action between its descending 50.0% and 61.8% Fibonacci Retracement Fan levels.
The Bull Bear Power Indicator is bullish but below its descending trendline.
The average bearish trading volumes are higher than the average bullish trading volumes.
DGX underperformed the S&P 500 Index over the past six weeks, a bearish confirmation.
My DGX Short Stock Trade
DGX Entry Level: Between $196.70 and $200.07
DGX Take Profit: Between $161.71 and $164.65
DGX Stop Loss: Between $213.50 and $218.47
Risk/Reward Ratio: 2.08
Ready to trade our analysis of Quest Diagnostics? Here is our list of the best stockbrokers worth reviewing.